Plain-English translation of ยท
This study doesn't follow the usual testing phases โ it may be an observational study or a different type of research.
This trial is testing whether pregnant women who are taking to prevent a serious condition called preeclampsia can safely stop the medication around 24โ28 weeks of pregnancy. The study compares two groups: one group continues until 36 weeks (current practice), and another group stops the medication at 24โ28 weeks if their blood work looks good. Researchers want to learn if stopping early is safe and might reduce unnecessary medication exposure.
Preeclampsia is a dangerous pregnancy condition that causes high blood pressure and can harm both mother and baby. is given to high-risk pregnant women to help prevent it, but doctors aren't sure if women can safely stop taking this medication partway through pregnancy if their blood work shows they're at lower risk later on.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
If you qualify, you will be randomly assigned to either continue taking until 36 weeks or to stop it around 24โ28 weeks (if your blood work supports stopping). You'll have regular prenatal visits and blood tests as part of standard pregnancy care. Researchers will track your blood pressure measurements and monitor you and your baby throughout the rest of your pregnancy and after delivery to see if stopping the medication early is safe.
AI-generated summary from trial data ยท Jun 22, 2026 ยท Not medical advice
Norway